Metric Deep Dive: Understanding Cullinan Therapeutics Inc (CGEM) Through its Ratios

In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.

After finishing at $11.49 in the prior trading day, Cullinan Therapeutics Inc (NASDAQ: CGEM) closed at $10.77, down -6.27%. In other words, the price has decreased by -$6.27 from its previous closing price. On the day, 0.74 million shares were traded. CGEM stock price reached its highest trading level at $11.5 during the session, while it also had its lowest trading level at $10.55.

Ratios:

Our goal is to gain a better understanding of CGEM by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 24.46 and its Current Ratio is at 24.46. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, UBS on October 24, 2024, initiated with a Buy rating and assigned the stock a target price of $30.

On May 01, 2024, Stifel started tracking the stock assigning a Buy rating and target price of $40.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Dec 12 ’24 when Michaelson Jennifer sold 3,489 shares for $12.52 per share. The transaction valued at 43,682 led to the insider holds 104,453 shares of the business.

Michaelson Jennifer sold 8,000 shares of CGEM for $125,120 on Nov 05 ’24. The Chief Scientific Officer now owns 107,942 shares after completing the transaction at $15.64 per share. On Sep 05 ’24, another insider, Michaelson Jennifer, who serves as the Chief Scientific Officer of the company, sold 8,000 shares for $18.09 each. As a result, the insider received 144,720 and left with 115,942 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CGEM now has a Market Capitalization of 627111296 and an Enterprise Value of 51479176.

Stock Price History:

Over the past 52 weeks, CGEM has reached a high of $30.19, while it has fallen to a 52-week low of $8.02. The 50-Day Moving Average of the stock is -25.84%, while the 200-Day Moving Average is calculated to be -39.87%.

Shares Statistics:

The stock has traded on average 534.83K shares per day over the past 3-months and 458470 shares per day over the last 10 days, according to various share statistics. A total of 58.14M shares are outstanding, with a floating share count of 37.15M. Insiders hold about 36.20% of the company’s shares, while institutions hold 77.32% stake in the company. Shares short for CGEM as of 1732838400 were 9157765 with a Short Ratio of 17.12, compared to 1730332800 on 9021016. Therefore, it implies a Short% of Shares Outstanding of 9157765 and a Short% of Float of 18.23.

Most Popular